Substantially pure solid form of the enol tautomer of 3-indolypyruvic acid for use in the treatment of central nervous system disturbances
EP1019434A2
Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis
US6057297A
Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof
WO9745127A1
Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders
US5962459A
Therapeutic active agent for treatment of neuron degenerative diseases
HU0000124A3
Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders
EP0758021A2
Method for determining the therapeutic activity of metalloproteinase inhibitor compounds, new inhibitor compounds, and the therapeutic use thereof
US5504071A
Compounds with a sequence of three radicals, the central one being α-a
ITRM940505D0
Active agent for the treatment of chronic infections resulting from immunodepression and to hinder the growth of tumours encouraged by immunodepression
EP0608671A1
Use of 3-indolepyruvic acid to reduce the level of glucocorticoids in the blood and to prevent cerebral disturbances
CA2070169A1
Compounds with a sequence of three radicals, the central one being -aminoacidic and therapeutical applications thereof
AU8321691A
Therapeutic use of ranitidine in the treatment of wounds to the skin and underlying tissues
EP0462075A2
Use of uridine in the pharmacological treatment of the peripheral complications of diabetes
EP0421946A2
3-indolepyruvic acid derivatives their method of production and therapeutic use
EP0423077A1
Tripeptide compounds and their pharmaceutical use as immunomodulators
EP0412947A1
Cosmetic use of 3-indolepyruvic acid
US5075329A
Use of 3-indolepyruvic acid as a pharmaceutical agent for the inhibition of peripheral degenerative pathologies
CA1327003C
Pharmacological use of uridine in the treatment of nervous disorders
CA1328658C
3-indolepyruvic acid derivatives and pharmaceutical use thereof
CA1267148A
PROCESS FOR THE PRODUCTION OF INDOLE-.alpha.-KETOACIDS FROM THE RELATIVE .alpha.-AMINOACID, PARTICULARLY FOR THE PRODUCTION OF INDOLEPYRUVIC ACID
